Lacer Pharma Drug Patent Portfolio
Lacer Pharma owns 2 orange book drugs protected by 2 US patents Given below is the list of Lacer Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8962028 | Topical steroid composition and method | 19 Jun, 2033 | Active |
| US5135943 | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same | 31 May, 2014 | Expired |
Lacer Pharma's Family Patents
Lacer Pharma Drug List
Given below is the complete list of Lacer Pharma's drugs and the patents protecting them.
1. Ertaczo
Ertaczo is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5135943 | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
31 May, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ertaczo's drug page
2. Ultravate
Ultravate is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8962028 | Topical steroid composition and method |
19 Jun, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ultravate's drug page